Actively Recruiting
A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery
Led by Alume Biosciences, Inc. · Updated on 2024-10-28
64
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Feasibility study of Bevonescein to highlight Nerves and Ureter in patients undergoing Minimally Invasive Surgery
CONDITIONS
Official Title
A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must be at least 18 years old
- Planning to undergo minimally invasive abdominopelvic surgery
- Willing to provide informed consent
- Sexually active patients must agree to use acceptable contraception during the study and for 30 days after
- Females of childbearing potential must have a negative pregnancy test at screening and during the study
You will not qualify if you...
- Prior surgery at the intended surgical site
- Uncontrolled abnormal heart rhythm
- Moderate to severe kidney impairment
- History of fluorescein allergy
- History of drug-related anaphylactic reaction
- Any disease or condition that may interfere with participation
- Any condition the investigator considers a high risk for treatment compliance
- Use of any investigational drug or device within 30 days before screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California San Diego
San Diego, California, United States, 92037
Actively Recruiting
Research Team
B
Barbara Stephens
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here